Editorial: GPCR in Inflammatory and Cancer Diseases

被引:3
作者
Couvineau, Alain [1 ]
Gomariz, Rosa P. [2 ]
Tan, Yossan-Var [3 ]
机构
[1] Univ Paris, DHU UNITY, INSERM UMR1149,, Inflammat Res Ctr CRI,Team Inflammat Canc Digest, Paris, France
[2] Univ Complutense Madrid, Fac Biol & Med, Dept Cell Biol, Madrid, Spain
[3] Rouen Univ Hosp, Dept Immunol & Biotherapy, IRIB, INSERM PANTHER U1234,Univ Rouen Normandy, Rouen, France
来源
FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷
关键词
GPCR; inflammation; neurodegenerative diseases; cancer; neuropeptides; PROTEIN-COUPLED RECEPTORS;
D O I
10.3389/fendo.2020.588157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Editorial: Gut physiology-microbes and inflammatory diseases
    Priyamvada, Shubha
    Akhtar, Suhail
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [22] Editorial: Regulation of osteoclast differentiation in autoimmune and inflammatory diseases
    Lee, Sun-Kyeong
    Inforzato, Antonio
    Sobacchi, Cristina
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [23] Editorial: Antioxidants and inflammatory immune-related diseases
    Xu, Pengfei
    Huang, Zunnan
    Xu, Yanyong
    Liu, Huanxiang
    Liu, Yuyu
    Wang, Ling
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer
    Lin, Wan-Wan
    Hsieh, Shie-Liang
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (07) : 838 - 847
  • [25] GPCR-Hippo Signaling in Cancer
    Luo, Jiaqian
    Yu, Fa-Xing
    CELLS, 2019, 8 (05)
  • [26] Cancer risk in immune-mediated inflammatory diseases (IMID)
    Beyaert, Rudi
    Beaugerie, Laurent
    Van Assche, Gert
    Brochez, Lieve
    Renauld, Jean-Christophe
    Viguier, Manuelle
    Cocquyt, Veronique
    Jerusalem, Guy
    Machiels, Jean-Pascal
    Prenen, Hans
    Masson, Pierre
    Louis, Edouard
    De Keyser, Filip
    MOLECULAR CANCER, 2013, 12
  • [27] Editorial: Autoimmunity, Infection and Cancer, an Inflammatory Relationship With Intimate Implication to Cancer Prevention and Immunotherapy
    Chen, Zhibin
    DiPaolo, Richard J.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [28] NF-κB inhibitors for the treatment of inflammatory diseases and cancer
    Calzado, Marco A.
    Bacher, Susanne
    Schmitz, M. Lienhard
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (03) : 367 - 376
  • [29] Cancer risk in immune-mediated inflammatory diseases (IMID)
    Rudi Beyaert
    Laurent Beaugerie
    Gert Van Assche
    Lieve Brochez
    Jean-Christophe Renauld
    Manuelle Viguier
    Veronique Cocquyt
    Guy Jerusalem
    Jean-Pascal Machiels
    Hans Prenen
    Pierre Masson
    Edouard Louis
    Filip De Keyser
    Molecular Cancer, 12
  • [30] Endogenous Anti-Cancer Candidates in GPCR, ER Stress, and EMT
    Gundamaraju, Rohit
    Lu, Wenying
    Azimi, Iman
    Eri, Rajaraman
    Sohal, Sukhwinder Singh
    BIOMEDICINES, 2020, 8 (10) : 1 - 13